Free Trial

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Declares Dividend of $0.21

Reckitt Benckiser Group logo with Consumer Staples background

Key Points

  • Reckitt Benckiser Group PLC declared a dividend of $0.21, which will be paid to investors on September 25th, with an ex-dividend date of August 8th.
  • The dividend yield is notably high at 341.0%, attracting attention from investors.
  • The company's stock recently opened at $15.10, with a 1-year range between $10.43 and $15.25, indicating potential volatility in its stock price.
  • Want stock alerts on Reckitt Benckiser Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) announced a dividend on Friday, August 1st, investing.com reports. Shareholders of record on Monday, August 11th will be given a dividend of 0.2106 per share on Thursday, September 25th. This represents a dividend yield of 341.0%. The ex-dividend date is Friday, August 8th.

Reckitt Benckiser Group Trading Down 0.5%

Shares of OTCMKTS:RBGLY traded down $0.08 on Tuesday, hitting $14.84. The company's stock had a trading volume of 252,188 shares, compared to its average volume of 362,420. The company has a 50-day simple moving average of $13.98 and a 200 day simple moving average of $13.43. Reckitt Benckiser Group has a 1 year low of $10.43 and a 1 year high of $15.25. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.37 and a current ratio of 0.56.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Further Reading

Dividend History for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines